Four products are growing 60% to 757% — but only two of their undervalued suppliers have a filing-confirmed chain role

Asked:“Find the fastest growing products for both consumers and business… identify the entire supply chain feeding those fast growing products… confirm from their 10K filings… identify which of these suppliers have stocks trading below fair market value… obtain sentiment from reddit, twitter, and other social media… show which stocks are both undervalued and generating lots of investor excitement.”

Diligence scan dated September 2, 2026. Four fast-growth products were screened — Dell AI-optimized servers, Ray-Ban Meta smart glasses, Zepbound and PAC-3 MSE interceptors — then 182 deduplicated supply-chain evidence rows from company sites, filings and news were mapped into disclosed supplier networks, and a 10-name valuation shortlist was checked for filing-level chain confirmation. Growth figures use different metrics and periods; this is a high-growth screen, not an exhaustive ranking.

Reported growth of the four screened products

Percent growth as reported by each source; metrics and periods differ — hover for detail

The publicly disclosed supply chains

Each ribbon is a company linked to a product ecosystem; width = number of evidence rows (182 total). Hover a ribbon for the actual supplied items. Confirmed named links and ecosystem/technology partners are mixed here — the table below separates them.

Undervaluation shortlist vs chain confirmation

Source-reported analyst-target / fair-value upside ranges (%), not intrinsic value; dates and methods differ by source

Dell's own FY2026 Q4 release reports record AI-optimized server revenue of $9.0B, up 342% YoY, and its 10-K now breaks out AI-optimized servers as a category — Dell is the product OEM, with NVIDIA, AMD and Intel the confirmed silicon suppliers. investors.delltechnologies.com

L3Harris has explicit PAC-3 MSE propulsion confirmation — its largest PAC-3 propulsion agreement to date, nearly tripling production of solid rocket motors and attitude-control motors — alongside a source-reported ~30.7% upside. l3harris.com

Meta's FY2025 10-K explicitly describes Ray-Ban Meta and Oakley Meta AI glasses, making it the second filing-confirmed undervaluation candidate (source-reported upside ~35.7%–46.2%). sec.gov

West Pharmaceutical's headline 78% reported upside is the largest on the shortlist but lower-confidence: the detailed Zepbound evidence names Ypsomed, SHL Medical, Bachem, Wuxi AppTec and others — not West — so no direct tirzepatide role is confirmed. barchart.com

The requested “undervalued + lots of excitement” intersection is not conclusively established: the live social scan produced no defensible, comparable Reddit/X excitement metric for the shortlist. Dell is the closest watch-list candidate given Stocktwits coverage and multiple valuation sources. stocktwits.com

Valuation shortlist

Social-sentiment cells are shown as unresolved — no normalized volume/sentiment metric was extracted from Reddit, X or Stocktwits

Ticker	Company	Chain	Reported upside	Confirmation	Social excitement	Source

Method: growth screen of 5 product-growth records; 182 deduplicated supply-chain/news rows across four product ecosystems; 360 detailed product evidence rows (Ray-Ban Meta, Zepbound, Dell AI servers, PAC-3 MSE); 276 cross-source filing/valuation/sentiment rows shaped into a 10-company shortlist, deduplicated here to 6 tickers. Data gathered through September 2, 2026. Upside percentages are source-reported analyst-target or fair-value gaps at heterogeneous dates, not intrinsic valuations. Growth rates use different metrics and periods and are not directly comparable. “Entire supply chain” cannot be literally proven from public disclosures; this network is the fullest publicly disclosed and independently corroborated chain found in this scan. Public issuers file 10-K/20-F; private firms in the chain do not file 10-Ks. Suppliers with a single evidence row were folded into “other disclosed suppliers” in the flow for space. Not investment advice.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.